Inflammaging and endotoxemia are often blocking standard hormone therapies from working — by downregulating the receptors.
I joined Dr. Lexi Gonzales and Tom Blue at LongevityFest 2025 to talk about how liposomal peptides like BPC-157, KPV, and Thymulin address that upstream. Seal the gut, reset immune resilience, and the downstream interventions start working.
Related Articles
Dr. Shade’s Protocols
Weekly deep dives into real health problems, decoded through chemistry and systems biology. Each issue breaks down the catalyst, the mechanism, and the protocol that actually works.